Korean red ginseng extracts inhibit NLRP3 and AIM2 inflammasome activation

Immunology Letters

Volumn 158, Issue 1-2, 2014, Pages 143-150

  Kim, Jeeyoung ^a   Ahn, Huijeong ^a   Han, Byung Cheol ^b   Lee, Seung Ho ^b   Cho, Young Wook ^c   Kim, Cheon Ho ^a   Hong, Eui Ju ^e   An, Beum Soo ^d   Jeung, Eui Bae ^e   Lee, Geun Shik ^a  

^a Kangwon National University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Pusan National University   (South Korea)

^e Chungbuk National University   (South Korea)

Author keywords

AIM2; Cytokine; Inflammasome; Interleukin 1; Macrophages; Red ginseng extracts

Indexed keywords

CRYOPYRIN; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RG 1; GINSENOSIDE RH 3; INFLAMMASOME; INTERLEUKIN 1BETA; PROTEIN AIM2; RED GINSENG EXTRACT; UNCLASSIFIED DRUG; AIM2 PROTEIN, HUMAN; CARRIER PROTEIN; DNA BINDING PROTEIN; IL1B PROTEIN, MOUSE; NLRP3 PROTEIN, HUMAN; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; GINSENG; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; SEPTIC SHOCK; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; LISTERIA MONOCYTOGENES; METABOLISM; MICROBIOLOGY; PANAX; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; CARRIER PROTEINS; CELL LINE; DNA-BINDING PROTEINS; GINSENOSIDES; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LISTERIA MONOCYTOGENES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PANAX; PLANT EXTRACTS; SALMONELLA TYPHIMURIUM;

EID: 84892864728     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.12.017     Document Type: Article

References (46)

1. Baek S.H., Bae O.N., Park J.H. Recent methodology in ginseng analysis. Journal of Ginseng Research 2012, 36:119-134.
2. Kang S., Min H. Ginseng, the 'Immunity Boost': the effects of Panax ginseng on immune system. Journal of Ginseng Research 2012, 36:354-368.
3. Lu J.M., Yao Q., Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Current Vascular Pharmacology 2009, 7:293-302.
4. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology 1999, 58:1685-1693.
5. Lee Y.J., Chung E., Lee K.Y., Lee Y.H., Huh B., Lee S.K. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Molecular and Cellular Endocrinology 1997, 133:135-140.
6. Lee Y., Jin Y., Lim W., Ji S., Choi S., Jang S., et al. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. Journal of Steroid Biochemistry and Molecular Biology 2003, 84:463-468.
7. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
8. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell 2002, 10:417-426.
9. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annual Review of Cell and Developmental Biology 2012, 28:137-161.
10. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
11. Lamkanfi M., Dixit V.M. Modulation of inflammasome pathways by bacterial and viral pathogens. Journal of Immunology 2011, 187:597-602.
12. Lamkanfi M. Emerging inflammasome effector mechanisms. Nature Reviews Immunology 2011, 11:213-220.
13. McDermott M.F., Aksentijevich I., Galon J., McDermott E.M., Ogunkolade B.W., Centola M., et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97:133-144.
14. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger. Science 2010, 327:296-300.
15. Englen M.D., Valdez Y.E., Lehnert N.M., Lehnert B.E. Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. Journal of Immunological Methods 1995, 184:281-283.
16. Kim S., Bauernfeind F., Ablasser A., Hartmann G., Fitzgerald K.A., Latz E., et al. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. European Journal of Immunology 2010, 40:1545-1551.
17. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
18. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
19. Sauer J.D., Witte C.E., Zemansky J., Hanson B., Lauer P., Portnoy D.A. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host & Microbe 2010, 7:412-419.
20. Hofseth L.J., Wargovich M.J. Inflammation, cancer, and targets of ginseng. Journal of Nutrition 2007, 137:183S-185S.
21. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 2010, 11:136-140.
22. 2+ and cAMP. Nature 2012, 492:123-127.
23. Martinon F. Signaling by ROS drives inflammasome activation. European Journal of Immunology 2010, 40:616-619.
24. Sorbara M.T., Girardin S.E. Mitochondrial ROS fuel the inflammasome. Cell Research 2011, 21:558-560.
25. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
26. Murakami T., Ockinger J., Yu J., Byles V., McColl A., Hofer A.M., et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:11282-11287.
27. 2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nature Communications 2012, 3:1329.
28. Im G.J., Chang J.W., Choi J., Chae S.W., Ko E.J., Jung H.H. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytotherapy Research: PTR 2010, 24:614-621.
29. Hwang H.J., Kwak Y.S., Yoon G.A., Kang M.H., Park J.H., Lee B.K., et al. Combined effects of swim training and ginseng supplementation on exercise performance time, ROS, lymphocyte proliferation, and DNA damage following exhaustive exercise stress. International Journal for Vitamin and Nutrition Research/Internationale Zeitschrift fur Vitamin - und Ernahrungsforschung/Journal international de vitaminologie et de nutrition 2007, 77:289-296.
30. Lin E., Wang Y., Mehendale S., Sun S., Wang C.Z., Xie J.T., et al. Antioxidant protection by American ginseng in pancreatic beta-cells. American Journal of Chinese Medicine 2008, 36:981-988.
31. Kim Y.C., Kim S.R., Markelonis G.J., Oh T.H. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. Journal of Neuroscience Research 1998, 53:426-432.
32. Kim S.J., Jeong H.J., Yi B.J., Kang T.H., An N.H., Lee E.H., et al. Transgenic Panax ginseng inhibits the production of TNF-alpha, IL-6, and IL-8 as well as COX-2 expression in human mast cells. American Journal of Chinese Medicine 2007, 35:329-339.
33. 2+ channel currents in rat sensory neurons. European Journal of Pharmacology 2002, 436:151-158.
34. Ahn J.Y., Choi I.S., Shim J.Y., Yun E.K., Yun Y.S., Jeong G., et al. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. European Journal of Immunology 2006, 36:37-45.
35. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
36. Gu W., Kim K.A., Kim D.H., Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biological & Pharmaceutical Bulletin 2013, 36:102-107.
37. Gai Y., Ma Z., Yu X., Qu S., Sui D. Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats. Toxicology Mechanisms and Methods 2012, 22:584-591.
38. Park E.K., Choo M.K., Han M.J., Kim D.H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. International Archives of Allergy and Immunology 2004, 133:113-120.
39. Sun C., Gao W., Zhao B., Cheng L. Optimization of the selective preparation of 20(R)-ginsenoside Rg3 catalyzed by d,l-tartaric acid using response surface methodology. Fitoterapia 2013, 84:213-221.
40. Shin Y.M., Jung H.J., Choi W.Y., Lim C.J. Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines. Molecular Biology Reports 2013, 40:269-279.
41. Wen H., Ting J.P., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases - did Warburg miss inflammation. Nature Immunology 2012, 13:352-357.
42. Aksentijevich I., Masters S.L., Ferguson P.J., Dancey P., Frenkel J., van Royen-Kerkhoff A., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. New England Journal of Medicine 2009, 360:2426-2437.
43. Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013, 493:674-678.
44. Grant R.W., Dixit V.D. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Frontiers in Immunology 2013, 4:50.
45. Juliana C., Fernandes-Alnemri T., Wu J., Datta P., Solorzano L., Yu J.W., et al. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. Journal of Biological Chemistry 2010, 285:9792-9802.
46. Lamkanfi M., Mueller J.L., Vitari A.C., Misaghi S., Fedorova A., Deshayes K., et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. Journal of Cell Biology 2009, 187:61-70.